Company / FCF Margin
Traws Pharma, Inc. FCF Margin History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-13188.5%
FY2024
5-year range
-13188.5% / -956.8%
FY2020-FY2024
Trend
-82.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 6 years, ranging from -13188.5% in FY2024 to -956.8% in FY2020.
Based on SEC 10-K filings.
-13188.5% in FY2024 with a 5-year CAGR of -11335.8%.
Declined from -9995.7% to -13188.5% over the past 3 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -3192.8pp
- 5-Year Change
- -11335.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, fcf margin decreased 82.8% year-over-year.
- Peak fcf margin was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -13188.5% | -82.8% |
| FY2023 | -7215.9% | - |
| FY2022 | - | - |
| FY2021 | -9995.7% | -944.7% |
| FY2020 | -956.8% | +48.4% |
| FY2019 | -1852.7% | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | -7234.5% | -247011.3% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026